Evaluation of selective COX-2 inhibitor for the protection of intestinal mucosal damage in comparison to NSAID in patients with rheumatoid arthritis (Investigation by capsule endoscopy and measurement of biomarkers for rheumatoid arthritis)
Not Applicable
- Conditions
- Patients with rheumatoid arthritis
- Registration Number
- JPRN-UMIN000002554
- Lead Sponsor
- Osaka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients treated with biologics (anti-TNF antibody, anti-IL-6R antibody, etc) 2.Patients treated with corticosteroid(>10mg of prednisolone) 3.Patients treated with aspirin. 4.Patients treated with anti-ulcer drugs (misoprostol,teprenone,rebamipide,etc) 5. Patients with active peptic ulcer in stomach or duodenum
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method